First Commonwealth Finl (NYSE:FCF) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.43 by 9.3 percent. This is a 5.41 percent increase over earnings of $0.37 per share from the same period last year.
First Commonwealth Finl Q4 Adj. EPS $0.39 Misses $0.43 Estimate
First Commonwealth Finl (NYSE:FCF) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.43 by 9.3 percent. This is a 5.41 percent increase over earnings of $0.37 per share from
Related Posts
Freeline Therapeutics Outlines 2022 Corporate Priorities, Guidance
Promising execution in the clinic with programs in hemophilia B, Fabry disease and Gaucher disease; potential to deliver transformative therapies driven by Freeline’s differentiated platform
Data anticipated
Oppenheimer Maintains Outperform on CRISPR Therapeutics, Lowers Price Target to $122
Oppenheimer analyst Jay Olson maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Outperform and lowers the price target from $150 to $122.
scPharmaceuticals Q3 EPS $(0.37) Beats $(0.38) Estimate
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 54.17 percent decrease over losses of $(0.24) per share from